EMPACOMBOMET XR 12.5&1000

Empacombomet XR is an extended-release oral hypoglycemic medication combining two active ingredients: Empagliflozin, an SGLT2 inhibitor, and Metformin Hydrochloride, a biguanide. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin works by helping the kidneys get rid of glucose from your bloodstream, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation allows for convenient once-daily dosing.